Acceleration Partners (Donors)
OvaCure has an operational partner, who covers all administrative costs until 2019. Thus, all other contributions are channeled without deductions to the development, launch and ongoing support of our clinical research projects.
- Dagmar & Leon Levin's Fond samt C.A Levin's Fond
- Danish Agency for Science Technology and Innovation
- Det Arnstedtske Familiefond
- Det Obelske Familiefond
- Fabrikan Chas. Otzen's Fond
- Hans og Nora Buchards Fond
- Ida og J. Rindoms Fond
Scientific Partner: Anticancer Fund
The Anticancer Fund is a not-for-profit organisation providing research-based information about cancer therapies and selectively funding the development of promising therapies. The Anticancer Fund targets crucial research projects which are often deemed as uninteresting from a commercial point of view.
The Fund finance the most promising treatments based on measurable outputs and are supported by a high-level advisory board as well as partnerships with international organizations. The primary goal of the Fund is to provide funding for the development of potential breakthrough therapies.
A special thanks to our competency partners for their invaluable time, resources and expertise.
An extended thank you to our contributors for supporting OvaCure.